Slingshot members are tracking this event:

FDA Accepts Biologics License Application For Subcutaneous Formulation Of Rituximab

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
RHHBY Community voting in process
HALO Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Nov 03, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Rituximab